These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6533950)

  • 21. Monitoring of extracorporeal membrane oxygenation with a PDP 8/e computer.
    Luzzana M; Musetti A; Agostoni A; Bernasconi C; Stabilini R; Uziel L; Damia G; Pesenti A; Piolini M
    Bull Eur Physiopathol Respir; 1977; 13(4):533-9. PubMed ID: 912140
    [No Abstract]   [Full Text] [Related]  

  • 22. Surface-heparinized neonatal ECMO circuit--an experimental animal study.
    Frenckner B; Ehrén H; Palmér K; Gouda I; Larm O; Olsson P
    Perfusion; 1992 Jan; 7(1):47-51. PubMed ID: 10147699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal lung assist (ELA) in adults: indications and application.
    Germann P; Ullrich R; Donner A; Urak G; Kneifel W; Hartmann T; Röder G; Zimpfer M
    Acta Anaesthesiol Scand Suppl; 1997; 111():132-5. PubMed ID: 9420985
    [No Abstract]   [Full Text] [Related]  

  • 24. Developing a small animal model of extracorporeal circulation.
    Skrzypchak AM; Miskulin J; Bartlett RH; Annich GM
    ASAIO J; 2006; 52(3):296-302. PubMed ID: 16760719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term extracorporeal circulation using membrane oxygenators].
    Laurent D; Gourgon R; Sadoul P
    Nouv Presse Med; 1973 Dec; 2(44):2931-4. PubMed ID: 4204463
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved tissue perfusion (PO2 histograms) in extracorporeal circulation using membrane instead of bubble oxygenators.
    Pranger RL; Mook PH; Elstrodt JM; Kessler M; Lübbers DW; Wildevuur CR
    J Thorac Cardiovasc Surg; 1980 Apr; 79(4):513-22. PubMed ID: 7359930
    [No Abstract]   [Full Text] [Related]  

  • 27. [Heart surgery with extracorporeal circulation using alpha membrane oxygenator. Personal experience in 150 cases].
    Vieira GL; da Silva RR; de Oliveira HG; Ribeiro S; Pavan WL; Jorge JC; de Carvalho LF; Rabello SC
    Arq Bras Cardiol; 1980 Oct; 35(4):287-90. PubMed ID: 7213109
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thrombosis-resistant heparin-coated diffusion membrane oxygenators: an experimental study].
    Tkebuchava T; von Segesser LK; Leskosek B; Pei P; Turina M
    Swiss Surg Suppl; 1996; Suppl 1():36-40. PubMed ID: 8653573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observations of acute thrombogenesis in membrane oxygenators.
    Friedman LI; Richardson PD; Galletti PM
    Trans Am Soc Artif Intern Organs; 1971; 17():369-75. PubMed ID: 5158119
    [No Abstract]   [Full Text] [Related]  

  • 31. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
    Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
    Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The benefit of heparin-bound circuits.
    Moulijn AC; Amsel BJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):557-8. PubMed ID: 8751535
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding.
    Esquivel CO; Björck CG; Bergentz SE; Bergqvist D; Larsson R; Carson SN; Dougan P; Nilsson B
    Surgery; 1984 Jan; 95(1):102-7. PubMed ID: 6691173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous release of a heparin-like factor during extracorporeal circulation in dog.
    Paul J; Belleville J; Cornillon B; Dureau G; Eloy R
    Life Support Syst; 1983; 1 Suppl 1():357-60. PubMed ID: 6336444
    [No Abstract]   [Full Text] [Related]  

  • 35. [Field parameter studies of hollow fiber membrane oxygenator systems for extracorporeal blood circulation].
    Liebrecht K; Uhlemann J; Kahnig R; Schmidt V; Freyer R; St Schüler S
    Biomed Tech (Berl); 1998; 43 Suppl():330-1. PubMed ID: 9859384
    [No Abstract]   [Full Text] [Related]  

  • 36. Extracorporeal membrane oxygenation for patients with cardiogenic shock.
    Pennington DG; Merjavy JP; Codd JE; Swartz MT; Miller LL; Williams GA
    Circulation; 1984 Sep; 70(3 Pt 2):I130-7. PubMed ID: 6744558
    [No Abstract]   [Full Text] [Related]  

  • 37. 24-hour membrane oxygenation without systemic heparin.
    Whitley DE; Meals CR; Eberle JW; Browning R; Manton JR; Somerville P; Rea WJ
    Surg Forum; 1972; 23(0):224-5. PubMed ID: 4671083
    [No Abstract]   [Full Text] [Related]  

  • 38. [Extracorporeal membrane oxygenation in the treatment of severe respiratory failure in children].
    Goitein KJ; Hardesty RL
    Harefuah; 1982 Dec; 103(11):310-1. PubMed ID: 7182341
    [No Abstract]   [Full Text] [Related]  

  • 39. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants.
    Böning A; Scheewe J; Ivers T; Friedrich C; Stieh J; Freitag S; Cremer JT
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1458-65. PubMed ID: 15116008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term membrane oxygenation without systemic heparinization.
    Rea WJ; Whitley D; Eberle JW
    Trans Am Soc Artif Intern Organs; 1972; 18(0):316-20, 333. PubMed ID: 4215189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.